FORT WORTH, Texas — Alcon’s ReStor multifocal IOL showed no difference in contrast sensitivity results from monofocal lenses, according to results of a multicenter trial. Almost 75% of patients ...

SALT LAKE CITY, UT--(Marketwired - Jun 14, 2017) - In March 2017, the U.S. Food and Drug Administration approved a new, advanced intraocular lens implant (IOL) called the Acrysof IQ ReSTOR® +2.5 ...

Bossier City, La.-based Zaffater Eye Center’s Norman Zaffater, MD, became the first physician in the Shreveport-Bossier area to implant the ReSTOR Multifocal TORIC intraocular lens, according to the ...

LONDON – Refractive lens exchange combined with LASIK can extend the indications for using a multifocal IOL to include patients with astigmatism, one surgeon told an audience at the European Society ...

Basel, March 23, 2017 - Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof® IQ ReSTOR® +2.5 ...

(RTTNews) - Alcon, a division of Novartis, announced it has received approval from the US FDA for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens with ACTIVEFOCUS optical design for ...

Novartis' ($NVS) Alcon received FDA approval for its implantable AcrySof IQ ReSTOR +2.5 Diopter intraocular lens (IOL), enabling vision correction at all distances in ...

In a near-unanimous vote, a US Food and Drug Administration (FDA) device panel endorsed Alcon Research, Ltd's AcrySof IQ ReSTOR multifocal toric posterior chamber intraocular lens (IOL). The proposed ...

Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens ...